Randomized Study of Hormonal Regulation of Infantile Hemangioma
Status:
Completed
Trial end date:
2000-06-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the clinical efficacy of leuprolide, a gonadotropin-releasing hormone
agonist (GnRHa), in treating infants with vision-endangering or large, disfiguring
hemangiomas.
II. Assess the impact of GnRHa on growth and development during infancy. III. Assess the
safety of GnHRa in these patients.
Phase:
N/A
Details
Lead Sponsor:
FDA Office of Orphan Products Development
Collaborators:
Boston Children's Hospital Boston Children’s Hospital